anastrozole has been researched along with Genital Neoplasms, Female in 1 studies
Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wheler, JJ | 1 |
| Moulder, SL | 1 |
| Naing, A | 1 |
| Janku, F | 1 |
| Piha-Paul, SA | 1 |
| Falchook, GS | 1 |
| Zinner, R | 1 |
| Tsimberidou, AM | 1 |
| Fu, S | 1 |
| Hong, DS | 1 |
| Atkins, JT | 1 |
| Yelensky, R | 1 |
| Stephens, PJ | 1 |
| Kurzrock, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance[NCT01197170] | Phase 1 | 277 participants (Actual) | Interventional | 2010-09-07 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for anastrozole and Genital Neoplasms, Female
| Article | Year |
|---|---|
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast | 2014 |